questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Tumeurs hématologiques
Tumeurs de la moelle osseuse
Tumeurs de la moelle osseuse : Questions médicales fréquentes
Termes MeSH sélectionnés :
Natural Language Processing
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs de la moelle osseuse : Questions médicales les plus fréquentes",
"headline": "Tumeurs de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-14",
"dateModified": "2025-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs de la moelle osseuse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs hématologiques",
"url": "https://questionsmedicales.fr/mesh/D019337",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs hématologiques",
"code": {
"@type": "MedicalCode",
"code": "D019337",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.400"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Polyglobulie primitive essentielle",
"alternateName": "Polycythemia Vera",
"url": "https://questionsmedicales.fr/mesh/D011087",
"about": {
"@type": "MedicalCondition",
"name": "Polyglobulie primitive essentielle",
"code": {
"@type": "MedicalCode",
"code": "D011087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.400.200.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la moelle osseuse",
"alternateName": "Bone Marrow Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D019046",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sa A Wang",
"url": "https://questionsmedicales.fr/author/Sa%20A%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, US."
}
},
{
"@type": "Person",
"name": "Adam Bagg",
"url": "https://questionsmedicales.fr/author/Adam%20Bagg",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, US."
}
},
{
"@type": "Person",
"name": "Robert P Hasserjian",
"url": "https://questionsmedicales.fr/author/Robert%20P%20Hasserjian",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Massachusetts General Hospital, Boston, MA, US."
}
},
{
"@type": "Person",
"name": "Eric D Hsi",
"url": "https://questionsmedicales.fr/author/Eric%20D%20Hsi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, US."
}
},
{
"@type": "Person",
"name": "Kathryn Foucar",
"url": "https://questionsmedicales.fr/author/Kathryn%20Foucar",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, University of New Mexico, Albuquerque, NM, US."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis.",
"datePublished": "2023-06-22",
"url": "https://questionsmedicales.fr/article/37349605",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10620-023-07993-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gastric Intestinal Metaplasia in Children: Natural History and Clinicopathological Correlation.",
"datePublished": "2023-06-15",
"url": "https://questionsmedicales.fr/article/37319118",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MPG.0000000000003862"
}
},
{
"@type": "ScholarlyArticle",
"name": "Atrazine Toxicity: The Possible Role of Natural Products for Effective Treatment.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37375903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/plants12122278"
}
},
{
"@type": "ScholarlyArticle",
"name": "Biofunctionalization of natural extracts, trends in biological activity and kinetic release.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37329675",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cis.2023.102938"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of Metabolite-Responsive Biosensors for Plant Natural Products Biosynthesis.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37366998",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/bios13060633"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs hématologiques",
"item": "https://questionsmedicales.fr/mesh/D019337"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs de la moelle osseuse",
"item": "https://questionsmedicales.fr/mesh/D019046"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs de la moelle osseuse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs de la moelle osseuse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs de la moelle osseuse",
"description": "Comment diagnostiquer une tumeur de la moelle osseuse ?\nQuels tests sont utilisés pour confirmer une tumeur ?\nQuels marqueurs tumoraux sont recherchés ?\nQuelle est l'importance de l'analyse cytogénétique ?\nLes tests génétiques sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Natural+Language+Processing&page=998#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs de la moelle osseuse",
"description": "Quels sont les symptômes courants des tumeurs de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle la santé globale ?\nLes symptômes varient-ils selon le type de tumeur ?\nY a-t-il des signes d'alerte précoce ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Natural+Language+Processing&page=998#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs de la moelle osseuse",
"description": "Peut-on prévenir les tumeurs de la moelle osseuse ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe tabagisme est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Natural+Language+Processing&page=998#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs de la moelle osseuse",
"description": "Quels traitements sont disponibles pour ces tumeurs ?\nLa radiothérapie est-elle efficace ?\nQu'est-ce que la thérapie ciblée ?\nQuand la greffe de moelle osseuse est-elle recommandée ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Natural+Language+Processing&page=998#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs de la moelle osseuse",
"description": "Quelles complications peuvent survenir ?\nComment les infections sont-elles liées aux tumeurs ?\nLes tumeurs de la moelle osseuse peuvent-elles récidiver ?\nQuelles sont les conséquences d'une anémie sévère ?\nLes traitements eux-mêmes peuvent-ils causer des complications ?",
"url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Natural+Language+Processing&page=998#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs de la moelle osseuse",
"description": "Quels sont les principaux facteurs de risque ?\nLes maladies génétiques augmentent-elles le risque ?\nLe sexe influence-t-il le risque de tumeurs ?\nL'obésité est-elle un facteur de risque ?\nLes infections virales peuvent-elles jouer un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D019046?mesh_terms=Natural+Language+Processing&page=998#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une tumeur de la moelle osseuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par biopsie de moelle osseuse et analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer une tumeur ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'imagerie comme l'IRM et la TDM sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont recherchés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs comme le B2-microglobuline et les chaînes légères d'immunoglobulines sont analysés."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'analyse cytogénétique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à identifier des anomalies chromosomiques spécifiques aux tumeurs."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations spécifiques liées aux tumeurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs de la moelle osseuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, douleurs osseuses, infections fréquentes et saignements anormaux."
}
},
{
"@type": "Question",
"name": "Comment la moelle osseuse affecte-t-elle la santé globale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner une anémie, des infections et des problèmes de coagulation."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de tumeur peut présenter des symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes d'alerte précoce ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements inexpliqués et des ecchymoses peuvent être des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être similaires à ceux d'autres maladies hématologiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs de la moelle osseuse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain aide."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques peut augmenter le risque de tumeurs."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est associé à un risque accru de plusieurs cancers, y compris ceux de la moelle."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancers hématologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs de la moelle."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ces tumeurs ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut réduire la taille des tumeurs et soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la thérapie ciblée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un traitement qui cible des anomalies spécifiques des cellules tumorales."
}
},
{
"@type": "Question",
"name": "Quand la greffe de moelle osseuse est-elle recommandée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent recommandée pour les cas avancés ou réfractaires aux traitements."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue et immunosuppression."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, anémie sévère et défaillance organique."
}
},
{
"@type": "Question",
"name": "Comment les infections sont-elles liées aux tumeurs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tumeurs peuvent affaiblir le système immunitaire, rendant les infections plus probables."
}
},
{
"@type": "Question",
"name": "Les tumeurs de la moelle osseuse peuvent-elles récidiver ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive après traitement, nécessitant un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une anémie sévère ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une anémie sévère peut entraîner une fatigue extrême et des complications cardiaques."
}
},
{
"@type": "Question",
"name": "Les traitements eux-mêmes peuvent-ils causer des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des effets secondaires graves."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, l'exposition à des radiations et des produits chimiques."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques augmentent-elles le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques comme le syndrome de Down augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de tumeurs ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines tumeurs de la moelle osseuse sont plus fréquentes chez les hommes."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à un risque accru de plusieurs types de cancers."
}
},
{
"@type": "Question",
"name": "Les infections virales peuvent-elles jouer un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de tumeurs."
}
}
]
}
]
}
Cavernous transformation of the portal vein can occur after portal vein thrombosis (PVT). In this study, we investigated clinical complications associated with cavernous transformation in the context ...
In this retrospective cohort analysis, 204 patients with cirrhosis and PVT with or without cavernous transformation were identified using MUSC's Clinical Data Warehouse between January 1, 2013, throug...
Of 204 patients, 41 (20%) had cavernous transformation. MELD, Child-Pugh, and Charlson Comorbidity Index scores were similar among groups. There were no significant differences in the prevalence of es...
Patients with cavernous transformation appeared to have better outcomes than those without cavernous transformation....
Gastric intestinal metaplasia (GIM) is defined as the replacement of the normal gastric epithelium by intestinal-type epithelium. GIM is considered a preneoplastic lesion for gastric adenocarcinoma in...
We conducted a retrospective study of children with GIM on gastric biopsies at Boston Children's Hospital between January 2013 and July 2019. Demographic, clinical, endoscopic, and histologic data wer...
Of 38 patients with GIM, 18 were male (47%), mean age of detection was 12.5 ± 5.05 years (range, 1-18 years). The most common histologic was chronic gastritis (47%). Complete GIM was present in 50% (1...
Most children with GIM had low-risk histologic subtype (complete/limited) for gastric cancer; GIM was rarely associated with H pylori gastritis in our cohort. Larger multicenter studies are needed to ...
There are various herbicides which were used in the agriculture industry. Atrazine (ATZ) is a chlorinated triazine herbicide that consists of a ring structure, known as the triazine ring, along with a...
The health benefits provided by plant matrices is due to the presence of certain compounds that, in studies carried out in vitro and in vivo, have shown to have biological activity in certain conditio...
Plant natural products (PNPs) have shown various pharmaceutical activities, possessing great potential in global markets. Microbial cell factories (MCFs) provide an economical and sustainable alternat...
Being a controller of cytoprotective actions, inflammation, and mitochondrial function through participating in the regulation of multiple genes in response to stress-inducing endogenous or exogenous ...
Bloom syndrome helicase (BLM) is a RecQ-family helicase implicated in a variety of cellular processes, including DNA replication, DNA repair, and telomere maintenance. Mutations in human BLM cause Blo...
In recent years, natural polysaccharides have been widely used in the preparation of drug delivery systems. In this paper, novel polysaccharide-based nanoparticles were prepared by layer-by-layer asse...
Overconsumption of added sugars is associated with higher incidences of obesity, type II diabetes, and cardiovascular disease. Alternative sweeteners have long been relied on as a strategy to reduce c...
We aimed to examine clinical features and outcomes of consecutive molecularly characterized patients with Noonan syndrome with multiple lentigines and hypertrophic cardiomyopathy....
A retrospective, longitudinal multicenter cohort of consecutive children and adults with a genetic diagnosis of Noonan syndrome with multiple lentigines and hypertrophic cardiomyopathy between 2002 an...
The cohort comprised 42 patients with Noonan syndrome with multiple lentigines and hypertrophic cardiomyopathy, with a median age at diagnosis of 3.5 (interquartile range, 0.2-12.3) years. Freedom fro...
These findings provide insights into the natural history of left ventricular hypertrophy, and can help inform clinicians regarding risk stratification and clinical outcomes in patients with Noonan syn...